Colonics
About Me
Recent Posts
- 'Personality Genes' May Help Account For Longevity
- 4 Mushroom Poisonings In 2 Weeks - Doctors Test Milk Thistle As Treatment
- Improved Diagnostics For Sleeping Sickness
- Prostate Growth May Be Slowed By Statins
- New Tools For Psychological Science Research - Facebook And Smartphones
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
Friends
Links
Entry 1 of 2381
Last Page | Next Page
12/8/2008
-
Rituxan In Combination With Chemotherapy Improves Progression-Free Survival In Difficult-to-Treat Form Of Blood Cancer
|
Genentech, Inc. (NYSE More: - Brought to my attention by |
Post A Comment! :: Send to a Friend! |
NA) and Biogen Idec (Nasdaq:BII
today announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan® (rituxima
plus chemotherapy significantly increased the time clients lived without their disease advancing, as defined by the primary endpoint of progression-free natural law (PFS), when compared to chemotherapy alone.Share and enjoy
